GPT and Cirrhosis: cfDNA levels and number of mutations increased from advanced fibrosis/cirrhosis to HCC, and cfDNA levels were positively correlated with non-invasive markers for liver fibrosis (APRI and NFS) and degree of hepatic damage (AST, ALT).